We are live on ! Find out more
DTRTU

DTRT Health Acquisition Corp. Unit

Delisted

DTRTU was delisted on the 26th of January, 2023.

2 hedge funds and large institutions have $20.1K invested in DTRT Health Acquisition Corp. Unit in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% less funds holding

Funds holding: 13 → 2 (-11)

100% less capital invested

Capital invested by funds: $6.2M → $20.1K (-$6.18M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 11

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-11
Holders Change %
-84.62%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

DTRTU Hedge Fund Activity: Q4 2022 in Review

2 of the 6,239 institutional investors tracked by Wall St. Rank reported a position in DTRT Health Acquisition Corp. Unit (DTRTU) for Q4 2022, worth a combined $20.1K — down 100% from $6.2M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of DTRTU and 0 opened new positions — a net loss of 11 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Landscape Capital Management, exiting entirely with an estimated $2.06M sold.

  • 2 institutional investors held DTRT Health Acquisition Corp. Unit (DTRTU) as of Q4 2022, down from 13 in Q3 2022.
  • Funds reported $20.1K of DTRT Health Acquisition Corp. Unit stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new DTRT Health Acquisition Corp. Unit positions in Q4 2022 and 11 closed out, a net change of -11 holders.
  • The largest DTRT Health Acquisition Corp. Unit seller in Q4 2022 was Landscape Capital Management, an estimated $2.06M sold.

Based on aggregated 13F filings for Q4 2022.